Rx-to-OTC Switch Movement

Rosenau, Pauline Vaillancourt

doi:10.1177/107755879405100403

Cited by 11 publications

(6 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Similarly to especially pharmacy owners in our study, also the physicians found that the Rx-OTC switch influenced them economically and professionally, although they saw it as inappropriate to admit the economical effect [56]. In our study, the majority of the responding Finnish pharmacists saw the importance of NRT products in SC not diminished.…”

Section: Discussionsupporting

confidence: 68%

Nicotine replacement therapy practices in Finland one year after deregulation of the product sales—Has anything changed from the community pharmacy perspective?

Kurko

Linden²,

Vasama

et al. 2009

Health Policy

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 68%

Nicotine replacement therapy practices in Finland one year after deregulation of the product sales—Has anything changed from the community pharmacy perspective?

Kurko

Linden²,

Vasama

et al. 2009

Health Policy

View full text Add to dashboard Cite

“…41 Examples include antihistamine agents for allergies, histamine-2 blockers, and PPIs for heartburn, antifungals for vaginal infections, and nonsteroidal antiinflammatory agents for pain and fever. 42 The total cost of acquiring a prescription medication may include the professional office visit, travel time and costs, and decreased productivity from missed work or school time, in addition to the costs associated with the medication. OTC availability decreases the cost in most incidences to only the purchase cost of the product, which is usually approximately 50% of the total cost of the same product by prescription.…”

Section: Regulatory Measuresmentioning

confidence: 99%

Evaluation of Rational Use of Medications in the United States

Lal

Rosenau

2010

J Prim Care Community Health

Self Cite

View full text Add to dashboard Cite

Rational medication use means taking medication appropriately for curing and relieving the symptoms of disease on the basis of evidence and sound judgment. We compare US policy experience on rational use of medications with the World Health Organization (WHO) list of interventions designed to promote such use. Current US performance and educational, managerial, and regulatory interventions to improve it are discussed. We conclude that, while most of the WHO guidelines for rational medication use are practiced in some form in one or more of the various US health care subsystems today, overall performance based on outcomes is not comparable with that of other industrialized countries. This is due to the absence of a national drug policy, the presence of a few strong stakeholders with committed policy preferences, and the altogether fragmented character of the US state and federal health systems. Practical suggestions are offered as to how the US could improve its overall less-than-optimal policies on rational medication use.

show abstract

“…[1][2][3][4][5] More than 600 OTC drugs now use ingredients and dosages that 20 years ago were available only by prescription. 2 The retail market value of these reclassifi ed products totals about $8.8 billion and will likely continue to increase in the future.…”

Section: Introductionmentioning

confidence: 99%

Consumer Knowledge of Over-the-Counter Phenazopyridine

Shi

Asch²,

Fielder³

et al. 2004

The Annals of Family Medicine

View full text Add to dashboard Cite

BACKGROUND Effective use of over-the-counter (OTC) medications depends on purchasers' knowledge of their indications. This study examines consumer knowledge regarding the urinary tract analgesic phenazopyridine, which recently became available without prescription.METHOD We conducted a cross-sectional survey of a stratifi ed cluster random sample of purchasers of OTC phenazopyridine (N = 434) in 31 Los Angeles retail pharmacies. RESULTSThe response rate was 58%. Only 29% correctly characterized the likely cause of their symptoms, and only 57% correctly characterized the action of the drug. Worse consumer knowledge was associated with nonwhite race, fi rst-time use, and less contact with health providers.CONCLUSION Many consumers possess poor knowledge about phenazopyridine, potentially leading to undertreatment, especially in groups with worse access to care.

show abstract

Rx-to-OTC Switch Movement

Cited by 11 publications

References 37 publications

Nicotine replacement therapy practices in Finland one year after deregulation of the product sales—Has anything changed from the community pharmacy perspective?

Nicotine replacement therapy practices in Finland one year after deregulation of the product sales—Has anything changed from the community pharmacy perspective?

Evaluation of Rational Use of Medications in the United States

Consumer Knowledge of Over-the-Counter Phenazopyridine

Contact Info

Product

Resources

About